{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:15:49Z","timestamp":1788923749348,"version":"build-2803163510"},"reference-count":75,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Inflammatory bowel disease (IBD), which includes Crohn\u2019s disease (CD) and ulcerative colitis (UC), can be associated with several extra-intestinal manifestations requiring a multidisciplinary management both in terms of work-up and therapy. Oral lesions are common in patients with IBD, with a prevalence ranging from 5% to 50%. These can represent an oral location of IBD as well as a side-effect of drugs used to treat the intestinal disease. Oral manifestations, occurring in patients with IBD, can be divided in nonmalignant, specific, and non-specific ones, and malignant lesions. While there is undoubtedly a need to search for an IBD in patients with oral lesions associated with intestinal symptoms, the work-up of those with an exclusive oral lesion should be personalized. Fecal calprotectin is a non-invasive marker of intestinal inflammation and may be used to select which patients need to undergo endoscopic examination, thereby avoiding unnecessary investigations. The pharmacological armamentarium to treat oral lesions associated with IBD includes topical or systemic corticosteroids, immunosuppressive agents, and biologic drugs.<\/jats:p>","DOI":"10.3390\/medicines7060033","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T13:20:43Z","timestamp":1592313643000},"page":"33","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3087","authenticated-orcid":false,"given":"Davide Giuseppe","family":"Ribaldone","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaggia","family":"Brigo","sequence":"additional","affiliation":[{"name":"Bow Lane Dental Group, St George\u2019s Hospital, Bupa Dental Care, London SW17 0QT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Mangia","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5310-4143","authenticated-orcid":false,"given":"Giorgio Maria","family":"Saracco","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Astegiano","sequence":"additional","affiliation":[{"name":"Unit of Gastroenterology, Molinette Hospital, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-0649","authenticated-orcid":false,"given":"Rinaldo","family":"Pellicano","sequence":"additional","affiliation":[{"name":"Unit of Gastroenterology, Molinette Hospital, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2004.02.072","article-title":"From symptom to diagnosis: Clinical distinctions among various forms of intestinal inflammation","volume":"126","author":"Sands","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The Prevalence of Extraintestinal Diseases in Inflammatory Bowel Disease: A Population-Based Study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ribaldone, D.G., Pellicano, R., and Actis, G.C. (2019). The gut and the Inflammatory Bowel Diseases inside-out: The extra-intestinal manifestations. Minerva Gastroenterol. Dietol.","DOI":"10.23736\/S1121-421X.19.02577-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"31","author":"Su","year":"2002","journal-title":"Gastroenterol. Clin. North Am."},{"key":"ref_6","first-page":"145","article-title":"Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease","volume":"56","author":"Adriani","year":"2014","journal-title":"Panminerva Med."},{"key":"ref_7","first-page":"579","article-title":"Ulcerative colitis and systemic lupus erythematosus","volume":"104","author":"Cantatore","year":"2013","journal-title":"Minerva Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200301000-00001","article-title":"A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease","volume":"9","author":"Silverberg","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2004.04.019","article-title":"Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes","volume":"127","author":"Langmann","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Caviglia, G.P., Rosso, C., Stalla, F., Rizzo, M., Massano, A., Abate, M.L., Olivero, A., Armandi, A., Vanni, E., and Younes, R. (2020). On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030800"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mari, A., Abu Baker, F., Mahamid, M., Sbeit, W., and Khoury, T. (2020). The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030685"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Ardizzone","year":"2008","journal-title":"Dig. Liver Dis."},{"key":"ref_14","first-page":"1237","article-title":"Crohn\u2019s disease of the mouth","volume":"62","author":"Dudeney","year":"1969","journal-title":"Proc. R. Soc. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/apt.13217","article-title":"Review article: Non-malignant oral manifestations in inflammatory bowel diseases","volume":"42","author":"Katsanos","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1067\/mpd.2001.113008","article-title":"The oral cavity in Crohn\u2019s disease","volume":"138","author":"Pittock","year":"2001","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lenaerts, C., Roy, C.C., Vaillancourt, M., Weber, A.M., Morin, C.L., and Seidman, E. (1989). High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics.","DOI":"10.1542\/peds.83.5.777"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dupuy, A., Cosnes, J., Revuz, J., Delchier, J.C., Gendre, J.P., and Cosnes, A. (1999). Oral Crohn disease: Clinical characteristics and long-term follow-up of 9 cases. Arch. Dermatol.","DOI":"10.1001\/archderm.135.4.439"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lauritano, D., Boccalari, E., Di Stasio, D., Della Vella, F., Carinci, F., Lucchese, A., and Petruzzi, M. (2019). Prevalence of oral lesions and correlation with intestinal symptoms of inflammatory bowel disease: A systematic review. Diagnostics, 9.","DOI":"10.3390\/diagnostics9030077"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Harty, S., Fleming, P., Rowland, M., Crushell, E., McDermott, M., Drumm, B., and Bourke, B. (2005). A prospective study of the oral manifestations of Crohn\u2019s disease. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/S1542-3565(05)00424-6"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5114\/ceji.2016.63131","article-title":"The relationship between the immune system and oral manifestations of inflammatory bowel disease: A review","volume":"41","author":"Vasovic","year":"2016","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_22","first-page":"274","article-title":"Crohn\u2019s disease masquerading as aphthous ulcers","volume":"8","author":"Rehberger","year":"1998","journal-title":"Eur. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0004-28032015000200006","article-title":"Oral mucosa lesions and oral symptoms in inflammatory bowel disease patients","volume":"52","author":"Laranjeira","year":"2015","journal-title":"Arq. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1468-3083.2009.03304.x","article-title":"Oral manifestations of inflammatory bowel disease: A review based on the observation of six cases","volume":"24","author":"Lourenco","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/dnares\/dst037","article-title":"Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers","volume":"21","author":"Said","year":"2014","journal-title":"DNA Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.3748\/wjg.v22.i25.5655","article-title":"Oral pathology in inflammatory bowel disease","volume":"22","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/MIB.0000000000000670","article-title":"Does Crohn\u2019s Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?","volume":"22","author":"Gale","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Halme, L., Meurman, J.H., Laine, P., von Smitten, K., Syrj\u00e4nen, S., Lindqvist, C., and Strand-Pettinen, I. (1993). Oral findings in patients with active or inactive Crohn\u2019s disease. Oral Surg. Oral Med. Oral Pathol.","DOI":"10.1016\/0030-4220(93)90200-N"},{"key":"ref_29","first-page":"289","article-title":"Orofacial Crohn\u2019s disease: An oral enigma","volume":"17","author":"Fatahzadeh","year":"2009","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gibson, J., Wray, D., and Bagg, J. (2000). Oral staphylococcal mucositis: A new clinical entity in or ofacial granulomatosisand Crohn\u2019s disease. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.","DOI":"10.1067\/moe.2000.101810"},{"key":"ref_31","first-page":"47","article-title":"Periodontal disease and anemias associated with Crohn\u2019s disease. A case report","volume":"78","author":"Nagpal","year":"2012","journal-title":"N. Y. State Dent. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.otohns.2005.03.070","article-title":"Tb or not Tb: Crohn\u2019s disease presenting with tonsillar granulomas","volume":"134","author":"Turchi","year":"2006","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Katz, J., Shenkman, A., Stavropoulos, F., and Melzer, E. (2003). Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis.","DOI":"10.1034\/j.1601-0825.2003.00879.x"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan","year":"2012","journal-title":"Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1085-5629(97)80025-9","article-title":"Diseases of the lips","volume":"16","author":"Rogers","year":"1997","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_36","first-page":"279","article-title":"Pyostomatitis vegetans associated with inflammatory bowel disease\u2014Report of two cases","volume":"34","author":"Licul","year":"2010","journal-title":"Coll. Antropol."},{"key":"ref_37","first-page":"ZD12","article-title":"Pyostomatitis Vegetans: A Clue for Diagnosis of Silent Crohn\u2019s Disease","volume":"10","author":"Lotfi","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Correll, R.W., Wescott, W.B., and Jensen, J.L. (1981). Recurring, painful oral ulcers. J. Am. Dent. Assoc.","DOI":"10.14219\/jada.archive.1981.0334"},{"key":"ref_39","first-page":"E114","article-title":"Pyostomatitis vegetans: A review of the literature","volume":"14","author":"Femiano","year":"2009","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Markopoulos, A.K., Antoniades, D.Z., and Gaga, E. (2005). Pyostomatitis Vegetans as an Oral Manifestation of Ulcerative Colitis: Report of Two Cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology.","DOI":"10.1016\/j.tripleo.2005.05.047"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jcpe.12698","article-title":"Inflammatory bowel disease and oral health: Systematic review and a meta-analysis","volume":"44","author":"Papageorgiou","year":"2017","journal-title":"J. Clin. Periodontol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0765.2011.01431.x","article-title":"The association between inflammatory bowel disease and periodontitis among Jordanians: A case-control study","volume":"47","author":"Habashneh","year":"2012","journal-title":"J. Periodont. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0765.2010.01303.x","article-title":"Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis","volume":"46","author":"Figueredo","year":"2011","journal-title":"J. Periodont. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.3748\/wjg.v22.i35.7963","article-title":"Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?","volume":"22","author":"Figueredo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kabbani, T.A., Koutroubakis, I.E., Schoen, R.E., Ramos-Rivers, C., Shah, N., Swoger, J., Regueiro, M., Barrie, A., Schwartz, M., and Hashash, J.G. (2016). Association of Vitamin D level with clinical status in inflammatory bowel disease: A 5-year longitudinal study. Am. J. Gastroenterol.","DOI":"10.1038\/ajg.2016.53"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Schroth, R.J., Rabbani, R., Loewen, G., and Moffatt, M.E. (2016). Vitamin D and Dental Caries in Children. J. Dent. Res.","DOI":"10.1177\/0022034515616335"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ibd.20983","article-title":"Looking in the mouth for Crohn\u2019s disease","volume":"16","author":"Rowland","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-3284-1-8","article-title":"Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment","volume":"1","author":"Campisi","year":"2009","journal-title":"Head Neck Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ecco-jcc\/jjv122","article-title":"Oral cancer and oral precancerous lesions in inflammatory bowel diseases: A systematic review","volume":"9","author":"Katsanos","year":"2015","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Cammarota, T., Ribaldone, D.G., Resegotti, A., Repici, A., Danese, S., Fiorino, G., Sarno, A., Robotti, D., Debani, P., and Bonenti, G. (2013). Role of bowel ultrasound as a predictor of surgical recurrence of Crohn\u2019s disease. Scand. J. Gastroenterol., 48.","DOI":"10.3109\/00365521.2013.777774"},{"key":"ref_53","first-page":"335","article-title":"Intestinal ultrasonography in adults with Crohn\u2019s disease: A 2020 update","volume":"65","author":"Sarno","year":"2019","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_54","first-page":"319","article-title":"Magnetic resonance enterography","volume":"65","author":"Gatti","year":"2019","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2036.2011.04710.x","article-title":"Systematic review: The use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn\u2019s disease","volume":"34","author":"Bouzas","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of disease: Pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3748\/wjg.v13.i14.2028","article-title":"Utility of serological markers in inflammatory bowel diseases: gadget or magic?","volume":"13","author":"Papp","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_58","first-page":"428","article-title":"Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease","volume":"44","author":"Gao","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00054725-200108000-00003","article-title":"Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn\u2019s disease","volume":"7","author":"Sandborn","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ibd.20368","article-title":"Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease","volume":"14","author":"Simondi","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Malickova, K., Lakatos, P.L., Bortlik, M., Komarek, V., Janatkova, I., and Lukas, M. (2010). Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort. Eur. J. Gastroenterol. Hepatol.","DOI":"10.1097\/MEG.0b013e32832f5c7e"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ecco-jcc\/jjw021","article-title":"Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn\u2019s Disease","volume":"10","author":"Amcoff","year":"2016","journal-title":"J. Crohns. Colitis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.23736\/S0031-0808.18.03405-5","article-title":"Fecal calprotectin: Beyond intestinal organic diseases","volume":"60","author":"Caviglia","year":"2018","journal-title":"Panminerva Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/00365518809085785","article-title":"L1, a major granulocyte protein: Antigenic properties of its subunits","volume":"48","author":"Berntzen","year":"1988","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.2008.170019","article-title":"Monitoring disease activity by stool analyses: From occult blood to molecular markers of intestinal inflammation and damage","volume":"58","author":"Foell","year":"2009","journal-title":"Gut"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Voganatsi, A., Panyutich, A., Miyasaki, K.T., and Murthy, R.K. (2001). Mechanism of extracellular release of human neutrophil calprotectin complex. J. Leukoc. Biol.","DOI":"10.1189\/jlb.70.1.130"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Burri, E., and Beglinger, C. (2011). Faecal calprotectin in the diagnosis of inflammatory bowel disease. Biochem. Med., 245\u2013253.","DOI":"10.11613\/BM.2011.034"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.crohns.2011.08.008","article-title":"Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome","volume":"6","author":"Sydora","year":"2012","journal-title":"J. Crohns. Colitis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/00365521.2011.551835","article-title":"Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy","volume":"46","author":"Koulaouzidis","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000442935","article-title":"Calprotectin or Lactoferrin: Do They Help","volume":"34","author":"Wright","year":"2016","journal-title":"Dig. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ojha, J., Cohen, D.M., Islam, N.M., Stewart, C.M., Katz, J., and Bhattacharyya, I. (2007). Gingival involvement in Crohn disease. J. Am. Dent. Assoc.","DOI":"10.14219\/jada.archive.2007.0106"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.crohns.2011.07.001","article-title":"Oral Crohn\u2019s disease: Is it a separable disease from orofacial granulomatosis? A review","volume":"6","author":"Zbar","year":"2012","journal-title":"J. Crohns. Colitis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0016-5085(72)80183-5","article-title":"Crohn\u2019s disease of the mouth","volume":"62","author":"Bishop","year":"1972","journal-title":"Gastroenterology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00016480310015326","article-title":"Crohn\u2019s disease manifesting in the head and neck","volume":"124","author":"Bradley","year":"2004","journal-title":"Acta Otolaryngol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Khouri, J.M., Bohane, T.D., and Day, A.S. (2005). Is orofacial granulomatosis in children a feature of Crohn\u2019s disease?. Acta Paediatr. Int. J. Paediatr.","DOI":"10.1111\/j.1651-2227.2005.tb01925.x"}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/6\/33\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:28Z","timestamp":1760175568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/6\/33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["medicines7060033"],"URL":"https:\/\/doi.org\/10.3390\/medicines7060033","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]}}}